Structure Therapeutics Inc. – Filings and Transcripts

NASDAQ: GPCR
Share price (6/22/26): $45.51
Market cap (6/22/26): $3.235 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Automatic shelf registration

Ownership Filter

Waldstreicher Joanne

Russell Angus C.

News Filter

Shareholder Vote Results

Reports First Quarter 2026 Financial Results and Recent Highlights

Appoints Matthew Lang, J.D. as Chief Operating Officer and General Counsel

Reports Positive Topline Data From Phase 2 ACCESS II Trial With Once-Daily Oral Small Molecule GLP-1 Receptor Agonist, Aleniglipron

Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Highlights

Proxies Filter

Definitive proxy

Definitive proxy

Definitive proxy

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness

Letter from the SEC

Correspondence with the SEC